Warning letterFDA · Sep 7, 2021
Lysulin, Inc. MARCS-CMS 614517, September 07, 2021
Named company: Lysulin, Inc.
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, your “Lysulin ® Weight Loss Shake,” “Lysulin…
Lot information: not specified in this record.